Press Release 27 November 2023 White & Case Advises Athyrium Capital Management on the Restructuring of RevitaLid Pharmaceutical Corp. and its Subsidiaries
Press Release 02 October 2023 White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC
Press Release 20 April 2023 White & Case Advises Air Water Ventures Ltd. on Business Combination with Athena Technology Acquisition Corp. II
Press Release 18 April 2023 White & Case Advises Graf Acquisition Corp. IV on Business Combination with NkGen Biotech, Inc.
Press Release 01 February 2023 White & Case Advises Biosynex on Merger Agreement With Chembio Diagnostics, Inc.
Press Release 30 January 2023 White & Case Advises Ross Acquisition Corp II on Its Business Combination with Aprinoia Therapeutics, Inc.
Press Release 10 November 2022 White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc.
Press Release 14 September 2022 White & Case advises Apollomics Inc. on its US$899 million business combination with Maxpro Capital Acquisition Corp.
Press Release 18 May 2022 White & Case advises LOTTE Corporation on US$160 million acquisition of pharmaceutical manufacturing facility from Bristol Myers Squibb
Press Release 06 May 2022 White & Case Advises ADVANZ PHARMA on Acquisition of Intercept Pharmaceuticals
Press Release 18 January 2022 White & Case Advises Dominus Capital on its Investment in Uptime Institute
Press Release 12 May 2021 White & Case Advises Soaring Eagle Acquisition Corp. on Its Business Combination with Ginkgo Bioworks
Press Release 29 March 2021 White & Case Advises CM Life Sciences II on Business Combination with SomaLogic
Press Release 07 January 2021 White & Case Advises Angelini Pharma on Up to US$960 Million Acquisition of Arvelle Therapeutics
